Schedule 13G ownership disclosure
CONSTELLATION PHARMACEUTICALS INC
Security class unavailable · CUSIP: 210373106
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 3.8560%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000315066-20-000883
- Form type
- SC 13G
- Filer
- CONSTELLATION PHARMACEUTICALS INC
- CIK
- CIK 1434418
- Filed
- Feb 07, 2020
- Reporting period
- —
- Description
- Schedule 13G beneficial ownership